Better Business Bureau finds that Soft Gel, Option did not misrepresent claims for Clarinol
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Monday determined that Soft Gel Technologies and Optio Health Products Inc. have provided adequate substantiation for claims made in print advertising and on product packaging for Clarinol CLA, a dietary supplement. Claims included:
· “Assists in reducing body fat and maintaining lean muscle tissue for healthy body
· “PureGels Clarinol CLA. For Healthy Body Composition;”
· “Clarinol CLA (Conjugated Linoleic Acid) has been proven in Clarinol-specific clinicals to help attain and sustain proper ratios of fat to lean muscle tissue;”
· “The clinical results show enhanced fat burning, lean muscle retention, and promotion of optimal BMI [Body Mass Index];”
· “PureGels Clarinol CLA in a soft gel is a powerful supplement from natural safflower oil which will help you Reshape Up!”
At the outset, the advertiser explained that Conjugated Linoleic Acid, the active ingredient in Clarinol, is an oil that exists naturally in foods such as dairy and meat products. Clarinol is marketed as a dietary supplement that assists in the reduction of fat mass and increase in lean mass in order to improve body composition.
NAD examined evidence in support of the advertising claims that included one study on the actual product and many on the active ingredient and determined that the studies followed sound methodologies and produced statistically significant results demonstrating a reduction in body fat mass, BMI, waist, waist-to-hip ratio and fat mass around the legs and abdomen, as well as an increase in lean mass.
Following its review of the evidence, NAD determined that the advertiser provided a reasonable basis for the claims at issue.
The company, in its advertiser’s statement, said it “appreciates the opportunity to participate in this proceeding and is pleased with the NAD’s conclusion.”
Data shows use of Alli could also impact household members’ habits
PHOENIX and PITTSBURGH New data released during proceedings at this year’s Scientific Meeting of The Obesity Society said that people taking FDA-approved weight-loss pill Alli also tend to make healthier grocery shopping decisions, a trend that is positively influencing families.
A 26-week study reviewed the shopping habits of 15,156 households in which one or more members were taking Alli. The study showed that shoppers in these households were also purchasing items such as cereals, diet control bars, multi-vitamins and yogurt, among other “healthy” options.
Study co-author, Rebecca Reeves, of Baylor College of Medicine, said, “What is so unique and exciting about the data in this abstract is the evidence that people taking Alli made changes in their purchase patterns toward healthier foods. These data show that households purchasing Alli more than once increased their buying of healthier products compared to the previous year.”
The National Institutes of Health have reported that about 65 percent of U.S. adults are obese or overweight. Persons dealing with too much weight are more likely to face health problems such as heart disease, hypertension and type 2 diabetes, the National Institutes said.
Taking Alli, combined with a low-calorie, encourages healthy, modest weight-loss, maker GlaxoSmithKline has said.
Nicotine gum helps pregnant women decrease amount of smoking, research says
WASHINGTON Although nicotine gum does not necessarily increase quit rates among pregnant women, the non-prescription smoking cessation product does help reduce the amount of smoking to the point that use of nicotine gum increased birth weight and gestational age, two key parameters in predicting neonatal wellbeing, new research published last week in the journal Obstetrics & Gynecology has found.
The study tracked pregnant women who smoked daily and received individualized behavioral counseling and random assignment to a 6-week treatment with 2-mg nicotine gum or placebo followed by a 6-week taper period. Women who did not quit smoking were instructed to reduce the number of cigarettes smoked by substituting with gum.
Using a completer analysis, nicotine gum significantly reduced the number of cigarettes smoked per day and cotinine concentration. Birth weights were significantly greater with nicotine gum compared with placebo. Gestational age was also greater with nicotine-replacement therapy than with placebo, the research found.